Honor Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -4357.90%
- Ebitda -9634.02%
- Net Worth -228.22%
- Total Assets 3464.08%
About Honor Pharmaceuticals
Honor Pharmaceuticals Limited (HPL) is a Public Limited Indian Non-Government Company incorporated in India on 07 August 2019 (Five years and five months 29 days old ). Its registered office is in Mira Road, Maharashtra.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
LocationMira Road, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304MH2019PLC329075
-
Company No.
329075
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
07 Aug 2019
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Honor Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Kumar
|
Director | 24-Jan-2020 | Current |
|
Vivek Chaudhary
|
Director | 07-Aug-2019 | Current |
|
Satyendra Singh
|
Additional Director | 12-May-2022 | Current |
Financial Performance of Honor Pharmaceuticals.
Honor Pharmaceuticals Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4357.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 228.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Honor Pharmaceuticals?
In 2021, Honor Pharmaceuticals had a promoter holding of 99.40% and a public holding of 0.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Honor Health India Private LimitedVivek Chaudhary is a mutual person
-
Dinkum Lifecare Private Limited
Vivek Chaudhary is a mutual person
-
Triglobal Lifesciences (Opc) Private Limited
Vivek Kumar is a mutual person
-
Five Star Medichem Healthcare Private Limited
Satyendra Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Honor Pharmaceuticals?
Unlock and access historical data on people associated with Honor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Honor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Honor Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
